Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SABS | ANIK | ELTX | ||
| Company | Sab Biotherapeutics Inc | Anika Therapeutics | Elicio Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.89 | 14.90 | 10.40 | ||
| High | 3.97 | 15.18 | 10.65 | ||
| Low | 3.83 | 14.56 | 10.24 | ||
| Latest | 3.88 | 14.80 | 10.65 | ||
| Change | +0.01 | -0.18 | -0.01 | ||
| % Change | +0.26% | -1.20% | -0.09% | ||
| Volume | 205,300 | 98,800 | 69,200 | ||
| 20-Day Average Volume | 986,340 | 128,730 | 129,950 | ||
| Previous Close | 3.87 | 14.98 | 10.66 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.95 | 14.40 | 11.29 | ||
| 20-Day Raw Stochastic | 15.89% | 74.37% | 20.23% | ||
| 20-Day Relative Strength | 48.84 | 65.31 | 50.36 | ||
| Weighted Alpha | +133.43 | +21.14 | +22.54 | ||
| Today's Opinion | 32% Buy | 100% Buy | 64% Buy | ||
| Previous Opinion | 32% Buy | 100% Buy | 64% Buy | ||
| Last Month's Opinion | 48% Buy | 88% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.31% since 03/26/26 | +0.34% since 03/26/26 | -1.57% since 03/26/26 | ||
| Low | 3.76 on 03/30/26 | 13.91 on 03/30/26 | 9.91 on 03/30/26 | ||
| High | 3.97 on 04/02/26 | 15.18 on 04/02/26 | 11.46 on 03/31/26 | ||
| 1-Month | |||||
| %Chg | -4.67% since 03/02/26 | +3.35% since 03/02/26 | -23.05% since 03/02/26 | ||
| Low | 3.64 on 03/06/26 | 13.70 on 03/20/26 | 9.91 on 03/30/26 | ||
| High | 5.15 on 03/12/26 | 15.18 on 04/02/26 | 13.84 on 03/03/26 | ||
| 3-Month | |||||
| %Chg | +2.92% since 01/02/26 | +58.29% since 01/02/26 | +32.30% since 01/02/26 | ||
| Low | 3.41 on 01/12/26 | 9.01 on 01/28/26 | 7.37 on 01/30/26 | ||
| High | 5.15 on 03/12/26 | 15.18 on 04/02/26 | 14.93 on 03/02/26 | ||
| 6-Month | |||||
| %Chg | +93.03% since 10/02/25 | +62.28% since 10/02/25 | -3.79% since 10/02/25 | ||
| Low | 1.97 on 10/03/25 | 8.67 on 10/17/25 | 7.37 on 01/30/26 | ||
| High | 5.15 on 03/12/26 | 15.18 on 04/02/26 | 14.93 on 03/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 197,690 | 198,335 | 195,917 | ||
| Shares Outstanding, K | 50,951 | 13,401 | 18,396 | ||
| Annual Sales | 0 | 112,820,000 | 0 | ||
| Annual Net Income | 13,270,000 | -10,880,000 | -39,570,000 | ||
| Last Quarter Sales | 0 | 30,620,000 | 0 | ||
| Last Quarter Net Income | -16,860,000 | 290,000 | -7,720,000 | ||
| 60-Month Beta | 0.60 | 0.28 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.46 on 03/09/26 | 0.31 on 02/26/26 | -0.49 on 03/12/26 | ||
| Latest Earnings Date | 05/08/26 | 05/08/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||